Abstract
In this educational post, I will delve into the nuances of Platelet-Rich Plasma (PRP) therapy, drawing from my clinical experience and the latest evidence-based research. We will explore the critical concepts of platelet concentration, the evolving understanding of leukocyte ratios (leukocyte-rich vs. leukocyte-poor PRP), and the paramount importance of dosing. I will break down the physiological mechanisms behind how PRP works, particularly in the context of joint arthritis and tendon injuries. Furthermore, I will explain how these advanced regenerative medicine concepts integrate seamlessly with a holistic, integrative chiropractic care model. This approach focuses not only on targeted biological repair but also on restoring the body's overall biomechanical function and systemic health, ultimately leading to more comprehensive and lasting patient outcomes.
The Critical Question of PRP Concentration and Patient Variability
A question I frequently encounter from both colleagues and patients is about the specifics of the Platelet-Rich Plasma (PRP) we use in our clinic. They often ask, "What concentration do you use?" and "Are you using leukocyte-rich or leukocyte-poor PRP for joints?" These are excellent and fundamentally important questions, and the answers are more complex than a simple number or a binary choice. The science of regenerative medicine is rapidly evolving, and our clinical protocols must keep pace.
In a recent case I was reviewing, the platelet concentration factor we achieved was approximately 7.5 times the patient's baseline platelet count. It is crucial to understand, however, that this number is not a fixed target but a result that can vary significantly from one patient to another. This variability stems from individual physiological differences—hydration status, nutritional health, age, and even the time of day the blood is drawn can all influence the final platelet concentration.
In my practice, where I have been utilizing our current processing system for nearly four years, I have the advantage of an in-house hematology analyzer. This tool allows me to precisely measure and verify our outcomes. My clinical observations consistently show that we achieve a concentration factor in the range of six to ten times (6x-10x) baseline. The key to achieving this robust concentration isn't just the patient's inherent biology but the meticulousness of the processing method. The goal is always to maximize the capture of viable, functional platelets, as these are the cellular powerhouses that drive the healing cascade.
Evolving Beyond Leukocyte-Rich vs. Leukocyte-Poor PRP
For many years, the regenerative medicine community has framed the PRP discussion in terms of leukocyte-rich versus leukocyte-poor preparations. This terminology, which gained traction around 2011-2012, was a significant step forward. It allowed us as clinicians to begin differentiating PRP products and conceptualizing how the presence or absence of white blood cells (leukocytes) might influence outcomes. The prevailing thought was that leukocyte-rich PRP (LR-PRP), with its higher concentration of white blood cells, might be more inflammatory and better suited for certain conditions like chronic tendinopathies, whereas leukocyte-poor PRP (LP-PRP) might be preferable for intra-articular injections, such as in an arthritic knee, to minimize a potential inflammatory flare.
This was a useful framework for its time. However, the scientific landscape is shifting. Groundbreaking research is compelling us to evolve beyond this simple dichotomy.
In a significant turn, a 2022 paper co-authored by the very same researchers who first popularized the leukocyte ratio debate presented new findings. Their research suggested that, specifically for joint arthritis, the distinction between leukocyte-rich and leukocyte-poor PRP may not significantly impact long-term outcomes. This revelation directs our attention to a potentially more critical variable: the absolute dose of platelets being delivered to the target tissue. The conversation is now moving from "What type of PRP is it?" to "How many platelets are we actually injecting?"
The Importance of Platelet Dosing: The New Frontier
The emerging paradigm focuses on platelet dosing—the total number of platelets administered in an injection. Think of it like a pharmaceutical prescription; a 10mg dose of a medication will have a different effect than a 100mg dose. The same principle applies to PRP. The biological response—the recruitment of stem cells, the moderation of inflammation, and the stimulation of tissue regeneration—is dose-dependent.
To achieve an effective dose, the processing system must be highly efficient at capturing platelets. The system I use is designed to isolate the buffy coat, the thin layer in centrifuged blood that lies between the red blood cells and the plasma. This buffy coat is extremely rich in platelets and a specific subset of leukocytes.
Buffy Coat Capture: Our system ensures we capture virtually all platelets in this layer.
Harvesting Additional Platelets: We have also learned, thanks to detailed cellular analysis, that a small portion of the upper red blood cell layer, previously discarded for fear of being overly inflammatory, contains a valuable population of platelets and beneficial white blood cells.
Beneficial Leukocytes: The primary white blood cells in this "reddish" layer are granulocytes, which can be pro-inflammatory if not managed. However, the process also captures lymphocytes and monocytes. These cells are critical. Monocytes, in particular, are driven by the signaling environment created by the platelets to differentiate into M2 macrophages, which are anti-inflammatory and play a crucial role in constructive tissue remodeling rather than destructive inflammation.
So, to summarize the answer to the initial question: We achieved a high concentration factor (7.5x in that specific case) by maximizing platelet capture. The focus has shifted away from a simple leukocyte ratio. Retrospective analyses of older studies suggest that systems labeled "leukocyte-rich" often simply had higher total platelet counts. It might be this higher platelet dose, combined with the beneficial actions of lymphocytes and monocytes, that explains why those preparations were often more effective, especially for stubborn tendon injuries.
The Role of Integrative Chiropractic Care in Regenerative Outcomes
This is where the principles of integrative chiropractic care become indispensable. Injecting a high dose of PRP into a dysfunctional joint or tendon is only one part of the equation. If the underlying biomechanical stresses that caused the initial injury are not addressed, the patient is likely to experience symptom recurrence. True healing requires a holistic approach that restores both biological integrity and mechanical function.
As a doctor of chiropractic, my first step is always a thorough biomechanical assessment.
Structural Analysis: I evaluate the patient’s posture, gait, and spinal alignment. An unlevel pelvis, a forward head posture, or scoliosis can create aberrant loading patterns on joints throughout the body, from the spine to the knees and ankles. These imbalances must be corrected.
Joint Mobility and Stability: Using manual adjustments and mobilization techniques, I work to restore proper motion to restricted joints. A joint that cannot move through its full, proper range of motion will experience concentrated stress on specific areas of cartilage, accelerating wear and tear. Conversely, hypermobile joints require targeted stabilization exercises to prevent injury.
Myofascial Release: Chronic muscle tension and fascial adhesions contribute significantly to joint dysfunction. I use techniques such as Active Release Technique (ART) and instrument-assisted soft tissue mobilization (IASTM) to break down scar tissue and restore normal muscle function. This reduces abnormal pull on tendons and joint capsules, creating a healthier mechanical environment for the PRP to work in.
The synergy between advanced regenerative injections and expert chiropractic care is profound. The PRP works on a cellular level to rebuild damaged tissue, while chiropractic adjustments and rehabilitative protocols correct the mechanical and neurological dysfunctions that led to the breakdown in the first place. This dual-pronged approach ensures that we are not just patching the problem but are rebuilding a stronger, more resilient, and better-functioning musculoskeletal system for the long term. My experience at our wellness centers has shown time and again that patients who engage in a comprehensive program combining regenerative medicine with chiropractic rehabilitation achieve faster, more complete, and more durable recoveries.
References
Cole, B. J., Gole, M., & St-Onge, E. (2022). Platelet-rich plasma: a narrative review of the evidence for its use in arthroscopic surgery. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 38(6), 2002-2005. https://doi.org/10.1016/j.arthro.2021.12.008
Gentile, P. (2020). The efficacy of platelet-rich plasma (PRP) in rheumatologic and musculoskeletal disorders. Annals of the Rheumatic Diseases, 79(Suppl 1), 108.
Kunutsor, S. K., & Laukkanen, J. A. (2022). Platelet-rich plasma in the management of knee osteoarthritis: an updated systematic review and meta-analysis of randomized controlled trials. Clinical Rheumatology, 41(12), 3587-3601. https://doi.org/10.1007/s10067-022-06307-8
Mariani, E., Caniglia, M., & Marcacci, M. (2021). The role of platelet-rich plasma in the management of patients with knee osteoarthritis: a comprehensive narrative review. International Journal of Molecular Sciences, 22(11), 5877. https://doi.org/10.3390/ijms22115877
The information herein is not intended to replace a one-on-one relationship with a qualified healthcare professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional. Our information scope is limited to chiropractic, musculoskeletal, and physical medicine, as well as wellness, sensitive health issues, and functional medicine articles, topics, and discussions. We provide and facilitate clinical collaboration with specialists across disciplines. Each specialist is governed by their professional scope of practice and the jurisdiction in which they are licensed. We utilize functional health and wellness protocols to treat and support care for musculoskeletal injuries or disorders. Our videos, posts, topics, subjects, and insights cover clinical matters and issues that directly or indirectly support our clinical scope of practice. Our office has made a reasonable effort to provide supportive citations and identify relevant research studies for our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez, DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multi-State Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
New York APRN License #: N25929, Verified: APRN-N25929*
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
My Digital Business Card
